HCPLive Network

New Agent Significantly Improves Progression-Free Survival in Patients With Advanced ER+ Breast Cancer

Combining the investigational PD 0332991 with letrozole as first-line therapy extended progression-free survival in women with advanced estrogen-receptor positive breast cancer.

Click here to view this article.

Further Reading
Adding spinal manipulative therapy to home exercise and advice may improve short-term outcomes in patients with subacute and chronic back-related leg pain, according to research published in the Sept. 16 issue of the Annals of Internal Medicine.
Watchful waiting may not be suitable for all men with early-stage prostate cancer, especially black patients, according to research published in Urologic Oncology.
Patients treated for two years with a combination of glatiramer acetate and estriol experienced a one-third reduction in relapse rate compared with patients who received glatiramer acetate and placebo.
A pair of medical experts – one from industry and one from academia – have teamed up to call for a new payment model for expensive gene therapies.
Breast feeding can potentially protect premature babies from a toxic gastrointestinal disease, according to a recent study published in in the American Journal of Pathology.
Patients on FVIII therapies may develop antibodies that diminish treatment efficacy, may not be able to handle frequent dosing schedules, and may not be able to afford the cost of treatment.
A drug that was approved less than 1 year ago to help with the prevention and treatment of bleeding in patients with hemophilia A may not have the desired effect, according to a recent study.
More Reading